BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 7097029)

  • 21. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD; Sosa RE; Vaughan ED; Scherr DS
    Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subclassifying atypical urinary cytology specimens.
    Renshaw AA
    Cancer; 2000 Aug; 90(4):222-9. PubMed ID: 10966562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between urinary cytology and pathology for nontransitional cell malignancies of the urinary tract.
    Raj GV; Bochner BH; Vickers A; Teper E; Lin O; Donat SM; Herr H; Dalbagni G
    J Urol; 2006 Jun; 175(6):2038-41; discussion 2041. PubMed ID: 16697796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Molecular changes in development and progression of urothelial carcinoma].
    Hartmann A
    Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.
    Dalbagni G; Han W; Zhang ZF; Cordon-Cardo C; Saigo P; Fair WR; Herr H; Kim N; Moore MA
    Clin Cancer Res; 1997 Sep; 3(9):1593-8. PubMed ID: 9815848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The value of upper tract cytology after transurethral resection of bladder tumor in patients with bladder transitional cell cancer.
    Sadek S; Soloway MS; Hook S; Civantos F
    J Urol; 1999 Jan; 161(1):77-9; discussion 79-80. PubMed ID: 10037373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.
    Kumar A; Kumar R; Gupta NP
    Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Voided urinary cytodiagnosis. Cyto-histologic comparison].
    Zerat L; Fontanière B; Claude JM; Potet F; Verges J
    Ann Urol (Paris); 1988; 22(4):249-53. PubMed ID: 3190165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Non-urothelial tumors of the urinary tract].
    Mikuz G
    Verh Dtsch Ges Pathol; 1993; 77():180-98. PubMed ID: 7511278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytokeratin expression patterns in low-grade papillary urothelial neoplasms of the urinary bladder.
    Ramos D; Navarro S; Villamón R; Gil-Salom M; Llombart-Bosch A
    Cancer; 2003 Apr; 97(8):1876-83. PubMed ID: 12673713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural history of positive urinary cytology after radical cystectomy.
    Raj GV; Bochner BH; Serio AM; Vickers A; Donat SM; Herr H; Lin O; Dalbagni G
    J Urol; 2006 Nov; 176(5):2000-5; discussion 2005. PubMed ID: 17070236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000.
    David KA; Mallin K; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
    Cancer; 2009 Apr; 115(7):1435-47. PubMed ID: 19215030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma.
    Veeramachaneni R; Nordberg ML; Shi R; Herrera GA; Turbat-Herrera EA
    Diagn Cytopathol; 2003 Jun; 28(6):301-7. PubMed ID: 12768634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for urothelial malignancies by cytologic analysis and flow cytometry in a community urologic practice: a prospective study.
    Gourlay W; Chan V; Gilks CB
    Mod Pathol; 1995 May; 8(4):394-7. PubMed ID: 7567937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of cytomorphometry and cytology in the diagnosis of transitional-cell carcinoma of the upper urinary tract.
    Seldenrijk CA; Verheggen WJ; Veldhuizen RW; Blok AP; Ooms EC
    Acta Cytol; 1987; 31(2):137-42. PubMed ID: 3469846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Urine cytology studies in bladder tumors].
    Albert L; Ebert W; Arndt J; Dietze B; Ulitzsch C
    Z Urol Nephrol; 1977 May; 70(4):231-6. PubMed ID: 899305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorescence in situ hybridization: a multitarget approach in diagnosis and management of urothelial cancer.
    Arentsen HC; de la Rosette JJ; de Reijke TM; Langbein S
    Expert Rev Mol Diagn; 2007 Jan; 7(1):11-9. PubMed ID: 17187480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic accuracy and key cytologic features of high-grade transitional cell carcinoma in the upper urinary tract.
    Potts SA; Thomas PA; Cohen MB; Raab SS
    Mod Pathol; 1997 Jul; 10(7):657-62. PubMed ID: 9237174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Squamous metaplasia mimicking papillary carcinoma in the upper urinary tract.
    Harada H; Seki T; Togashi M; Maruyama S; Tateno M; Takahashi A; Sato H; Hirano T
    Hokkaido Igaku Zasshi; 2004 Jan; 79(1):15-7. PubMed ID: 14978970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Voided urinary cytology in bladder cancer: is it time to review the indications?
    Talwar R; Sinha T; Karan SC; Doddamani D; Sandhu A; Sethi GS; Srivastava A; Narang V; Agarwal A; Adhlakha N
    Urology; 2007 Aug; 70(2):267-71. PubMed ID: 17826487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.